J. Bagel, “Secukinumab is Superior to Ustekinumab in Clearing Skin of Patients with Moderate to Severe Plaque Psoriasis: CLARITY, a Randomized, Controlled, Phase 3b Trial”, J of Skin, vol. 2, no. S1, p. S27, Feb. 2018.